echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nat Commun: Targeted therapy overcomes cancer tolerance.

    Nat Commun: Targeted therapy overcomes cancer tolerance.

    • Last Update: 2020-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    19, 2020 /--- -- A study led by McGill McGill University published in the journal Nature Communications suggests that inhibiting the OSMR gene can improve the effectiveness of radiation therapy.
    new insights into genes that control the energy produced by cancer stem cells could help find more effective treatments for glioblastoma.
    the method, developed by the Aarezu Jahani-Asl laboratory, an assistant professor of medicine at McGill University, was successful in preclinical mouse models, where the absence of OSMR genes led to a significant improvement in the response of tumors to treatment and longer life in mice.
    (Photo Source: www.pixabay.com) Glioblastoma has become the most common and invasive cancerous brain tumor in adults due to its resistance to treatment.
    treatment usually includes surgery, followed by chemotherapy and radiotherapy.
    these efforts, in most cases, tumor cells grow again after treatment and the cancer returns.
    glioblastoma tumor contains rare cancer stem cells and is key to tumor regeneration and therapeutic resistance.
    study, researchers found that OSMR enhances the unique role of cancer stem cells in treatment resistance by enhancing mitochondrials, the power generated by cellular energy.
    it takes a long time to reach mitochondrials and interacts with energy-producing machines, forcing them to produce more energy for cancer cells.
    to improve patients' response to glioblastoma treatment, we must find new weaknesses in cancer stem cells and overcome their resistance to treatment," said Jahani, a researcher at the center of the study.
    by inhibiting OSMR, we can stop the energy production of cancer stem cells and starve them to death.
    "s study suggests that the combination of targeted OSMR genes and radiation therapy could pave the way for future clinical trials to better treat glioblastoma tumors.
    say the next step is to use these tools in clinical trials.
    (bioon.com) Source: Gene targeting overcomes the resistance of brain cancer to the original source: Ahmad Sharanek et al. OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation, Nature Communications (2020). DOI: 10.1038/s41467-020-17885-z.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.